Skip to main content
Swing Capital

Fermenta Biotech Ltd

NSE: FERMENTA BSE: 506414Pharma

Incorporated in 1951, Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]

₹288
52W: ₹249 — ₹399
PE 11.5 · Book ₹137 · +110% vs book
Market Cap₹846 Cr
Stock P/E11.5Price to Earnings
ROCE19.9%Return on Capital
ROE20.7%Return on Equity
Div. Yield0.85%Face Value ₹5

Weaknesses

  • −The company has delivered a poor sales growth of 7.45% over past five years.
  • −Company has a low return on equity of 6.46% over last 3 years.

Shareholding Pattern

Promoters64.08%
FIIs0.02%
DIIs0%
Public33.32%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters62.06%62.06%62.06%64.08%▲2.064.08%64.08%64.08%64.08%
FIIs0%0.05%▲0.10.02%▼0.00.02%0.02%0.02%0.02%0.02%
DIIs0%0%0%0%0%0%0%0%
Public36.11%36.41%▲0.336.98%▲0.635%▼2.035%34.75%▼0.333.99%▼0.833.32%▼0.7

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales5189907390146122119107114
Expenses63638171749689968491
Operating Profit-122692155033232323
OPM %-23%30%10%2%17%34%27%19%21%21%
Net Profit-2812-7-583529161512
EPS ₹-9.513.98-2.46-1.652.7711.899.965.5154

AI Insights

Revenue Trend

TTM revenue at ₹462Cr, up 7.7% YoY. OPM at 22%.

Debt Position

Borrowings at ₹112Cr. Debt-to-equity ratio: 0.29x. Healthy balance sheet.

Capex Cycle

CWIP at ₹26Cr (12% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0.02% (+0.02pp change). Promoters hold 64.08%.

Margin & Efficiency

ROCE improving from 2% (Mar 2014) to 20% (Mar 2025). Working capital days: 51.

Valuation

PE 11.5x with 19.9% ROCE. Price is 110% above book value of ₹137. Dividend yield: 0.85%.

Recent Announcements